Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Depreciation & Amortization (CF) (2016 - 2025)

Medicure has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $86767.4 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 5.4% year-over-year to $86767.4; the TTM value through Dec 2025 reached $353818.8, up 10.62%, while the annual FY2025 figure was $354240.6, 12.98% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $86767.4 at Medicure, down from $100275.6 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $100275.6 in Q3 2025 and troughed at $70863.4 in Q3 2023.
  • A 5-year average of $83675.0 and a median of $84019.8 in 2023 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 53.27% in 2021 and later dropped 19.63% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $97580.3 in 2021, then fell by 10.91% to $86930.9 in 2022, then fell by 2.83% to $84471.6 in 2023, then dropped by 2.54% to $82322.7 in 2024, then grew by 5.4% to $86767.4 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for MCUJF at $86767.4 in Q4 2025, $100275.6 in Q3 2025, and $87327.2 in Q2 2025.